SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-106443
Filing Date
2023-10-03
Accepted
2023-10-03 17:00:26
Documents
16
Period of Report
2023-10-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2327475d1_8k.htm   iXBRL 8-K 34566
2 EXHIBIT 4.1 tm2327475d1_ex4-1.htm EX-4.1 117283
3 EXHIBIT 4.2 tm2327475d1_ex4-2.htm EX-4.2 117161
4 EXHIBIT 10.1 tm2327475d1_ex10-1.htm EX-10.1 29759
5 EXHIBIT 99.1 tm2327475d1_ex99-1.htm EX-99.1 15001
  Complete submission text file 0001104659-23-106443.txt   563745

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ckpt-20231002.xsd EX-101.SCH 3027
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE ckpt-20231002_lab.xml EX-101.LAB 34240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ckpt-20231002_pre.xml EX-101.PRE 22367
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2327475d1_8k_htm.xml XML 3414
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38128 | Film No.: 231305024
SIC: 2834 Pharmaceutical Preparations